期刊
JOURNAL OF LIPID RESEARCH
卷 58, 期 9, 页码 1765-1776出版社
ELSEVIER
DOI: 10.1194/jlr.S074039
关键词
cholesterol; dyslipidemias; lipoproteins statins; LDL cholesterol; adolescents; children; screening
Familial hypercholesterolemia (FH) is a common genetic disorder that causes elevated LDL cholesterol levels from birth. Untreated FH accelerates atherosclerosis and predisposes individuals to premature coronary artery disease (CAD) in adulthood. Mendelian randomization studies have demonstrated that LDL cholesterol has both a causal and cumulative effect on the risk of CAD. This supports clinical recommendations that children with FH commence pharmacological treatment from the age of 8 to 10 years, to reduce the burden of hypercholesterolemia. Worldwide, the majority of children with FH remain undiagnosed. Recent evidence suggests that the frequency of FH is at least 1 in 250 and this constitutes a public health issue. We review and identify the knowns and unknowns concerning the detection and management of pediatric FH that impact on the developing model of care for this condition.- Martin, A. C., S. S. Gidding, A. Wiegman, and G. F. Watts. Knowns and unknowns in the care of pediatric familial hypercholesterolemia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据